CN209691227U - A kind of drug use information management label - Google Patents
A kind of drug use information management label Download PDFInfo
- Publication number
- CN209691227U CN209691227U CN201920160694.3U CN201920160694U CN209691227U CN 209691227 U CN209691227 U CN 209691227U CN 201920160694 U CN201920160694 U CN 201920160694U CN 209691227 U CN209691227 U CN 209691227U
- Authority
- CN
- China
- Prior art keywords
- drug
- identifier portion
- mark part
- mark
- use information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The utility model relates to a kind of drug use informations to manage label, the label includes fixed part and mark part, the mark part successively includes indicating that drug has been used up first identifier portion, indicates the used second identifier portion of drug, indicates the original third mark part of drug, and cut-off rule is arranged between the first identifier portion, the second identifier portion and the third mark part.The utility model usually constructs drug use information management label, has standardized the management of drug, has facilitated the use of drug, can not only save medication, but also can the use of specification drug.
Description
Technical field
The utility model relates to a kind of management labels more particularly to a kind of drug use information to manage label.
Background technique
With the development of society, Hospital Drugs type is more and more, most of drug is directly to give patient's use, but have
A little drugs are that doctor uses to patient at any time, some in these drugs are big easy packagings, and doctor can repeatedly give multiple diseases
What people used.For these drugs, place within the hospital, need to pay close attention to its use information at any time, include whether be using being over
No used information.By the standardized administration to these drugs, medication can be not only saved, but also can the use of specification drug.
Present technology usually relies on user by observation and remembers to manage, and is so nonstandard for drug control.
Utility model content
The technical issues of the utility model solves is: constructing a kind of drug use information management label, overcomes the prior art
The nonstandard technical problem of drug control.
The technical solution of the utility model is: constructing a kind of drug use information management label, the label includes fixing
Portion and mark part, the mark part successively include indicating that drug has been used up first identifier portion, indicates drug used second
Mark part indicates the original third mark part of drug, the first identifier portion, the second identifier portion and the third mark
Cut-off rule is arranged between portion in knowledge.
The further technical solution of the utility model is: the first identifier portion, the second identifier portion and the third
Different colors is respectively set in mark part.
The further technical solution of the utility model is: the first identifier portion, the second identifier portion and the third
Mark part is successively arranged from top to bottom.
The further technical solution of the utility model is: the cut-off rule is the cut-off rule of easily openable.
The further technical solution of the utility model is: the first identifier portion, the second identifier portion and the third
Mark part successively from left to right or is from right to left arranged.
The further technical solution of the utility model is: the fixed part includes threading hole.
The further technical solution of the utility model is: the fixed part includes the adhesive-layer for stickup.
The further technical solution of the utility model is: identifying " having been used up " in the first identifier portion, second mark
Knowledge portion identifies " use ", and the third mark part successively identifies " being not used ".
The further technical solution of the utility model is: identifying " sky " in the first identifier portion, the second identifier portion
It identifies " enabling ", the third mark part successively identifies " full ".
The technical effect of the utility model is: constructing a kind of drug use information management label, the label includes fixing
Portion and mark part, the mark part successively include indicating that drug has been used up first identifier portion, indicates drug used second
Mark part indicates the original third mark part of drug, the first identifier portion, the second identifier portion and the third mark
Cut-off rule is arranged between portion in knowledge.The utility model usually constructs drug use information management label, has standardized the management of drug, side
Drug use, can not only save medication, but can specification drug use.
Detailed description of the invention
Fig. 1 is the structural schematic diagram of the utility model.
Specific embodiment
Combined with specific embodiments below, technical solutions of the utility model are further illustrated.
As shown in Figure 1, specific embodiment of the present utility model is: constructing a kind of drug use information management label, institute
Stating label includes fixed part 1 and mark part 2, and the mark part 2 successively includes indicating that drug has been used up first identifier portion 21, indicates
The used second identifier portion 22 of drug indicates the original third mark part 23 of drug, the first identifier portion 21, institute
State setting cut-off rule 25 between second identifier portion 22 and the third mark part 23.Drug was not used expression drug and was not opened an account
It used；Drug had used expression Key works Drug packing to be opened and had used, but had not used also；Drug has been used up expression drug
Using finishing, treatment of pharmaceutical products packaging is waited.
As shown in Figure 1, the specific implementation process of the utility model is: the label includes fixed part 1 and mark part 2, institute
It states fixed part 1 and is arranged for fixing drug use information management label, the usually described fixed part in drug use information management mark
The top of label.For the mark part 2 for identifying drug use information, the mark part 2 successively includes indicating that drug has been used up the
One mark part 21 indicates the used second identifier portion 22 of drug, indicates the original third mark part 23 of drug, described
Three parts of mark part identify the use information of drug respectively.The first identifier portion 21, the second identifier portion 22 and institute
State between third mark part 23 setting cut-off rule 25, the cut-off rule 25 is for separating the first identifier portion 21, described the
Two mark parts 22 and the third mark part 23, meanwhile, it is also convenient that the first identifier portion 21, institute are separated by the cut-off rule 25
State second identifier portion 22 and the third mark part 23.In specific embodiment, " having been used up " is identified in the first identifier portion,
The second identifier portion identifies " use ", and the third mark part successively identifies " being not used ".Another embodiment
In, " sky " is identified in the first identifier portion, the second identifier portion identifies " enabling ", and the third mark part successively identifies
" full ".
As shown in Figure 1, preferred embodiments of the present invention are: the first identifier portion 21, the second identifier portion
22 and the third mark part 23 different colors is respectively set, different colors is arranged in the various pieces of the mark part 2
It is the service condition that the different identification information of setting is used to distinguish the drug.
As shown in Figure 1, preferred embodiments of the present invention are: the first identifier portion 21, the second identifier portion
22 and the third identify 23 be successively arranged from top to bottom.It is had been used up since first identifier portion 21 indicates drug, second identifier
Portion 22 indicates that drug had used, third mark part 23 indicates that drug was not used, and expression not enabled mistake was not used in drug, this
When, medicine information needs to retain all information, and therefore, third mark part 23 should be in bottom.It had used but without making
It is finished, then the original mark needs of drug remove, that is, third mark part 23 removes, and retains the first identifier portion 21, institute
State second identifier portion 22.After drug is finished, at this point, drug had used the mark having had not been used that should remove, that is, described
Two mark parts 22 should remove, and should retain the first identifier portion 21 that drug has been used up at this time, therefore, for convenience of using, the mark
The first identifier portion 21, the second identifier portion 22 and the third mark part 23 is successively arranged in knowledge portion 2 from top to bottom.Specifically
In embodiment, the cut-off rule 25 is that the cut-off rule of easily openable drug every stage, then needs to tear in use
Fall the portion identification.The first identifier portion 21, the second identifier portion 22 and the third identify 23 successively from top to bottom
When setting, the topmost of drug use information management label is arranged in the fixed part 1.
As shown in Figure 1, preferred embodiments of the present invention are: the first identifier portion 21, the second identifier portion
22 and the third mark part 23 successively from left to right or be from right to left arranged, equally, the first identifier portion 21, described
The cut-off rule 25 of easily openable is set between two mark parts 22 and the third mark part 23.The first identifier portion 21, described
Two mark parts 22 and the third mark part 23 successively from left to right or are from right to left arranged, at this point, the fixed part 1 can be with
The top of the mark part 2 is set, also can be set in the lower part in the mark part 2, it is the first identifier portion 21, described
When second identifier portion 22 and the third mark part 23 are successively from left to right arranged, the fixed part 1 can also be arranged in described
The most left part of mark part 2.The first identifier portion 21, the second identifier portion 22 and the third mark part 23 are successively from right to left
When setting, the most right part of mark part 2 can also be arranged in the fixed part 1.
As shown in Figure 1, preferred embodiments of the present invention are: the fixed part 1 includes threading hole 11, threading hole 11
For threading, then line is tied up on Key works Drug packing.The fixed part 1 includes the adhesive-layer for stickup, and adhesive-layer is for gluing
Patch is fixed, and is easy to use, but be easy to fall.
The technical effect of the utility model is: constructing a kind of drug use information management label, the label includes fixing
Portion 1 and mark part 2, the mark part 2 successively include indicating that drug has been used up first identifier portion 21, indicates that drug is used
Second identifier portion 22 indicates the original third mark part 23 of drug, the first identifier portion 21, the second identifier portion 22
Cut-off rule 25 is set between the third mark part 23.The utility model usually constructs drug use information management label, rule
The model management of drug, facilitates the use of drug, can not only save medication, but can specification drug use.
It, cannot the above content is specific preferred embodiment further detailed description of the utility model is combined
Assert that the specific implementation of the utility model is only limited to these instructions.For the ordinary skill of the utility model technical field
For personnel, without departing from the concept of the premise utility, a number of simple deductions or replacements can also be made, should all regard
To belong to the protection scope of the utility model.
Claims (9)
1. a kind of drug use information manages label, which is characterized in that the label includes fixed part and mark part, the mark
Portion successively includes indicating that drug has been used up first identifier portion, indicates the used second identifier portion of drug, indicates that drug does not make
Cut-off rule is arranged between the first identifier portion, the second identifier portion and the third mark part in used third mark part.
2. drug use information manages label according to claim 1, which is characterized in that the first identifier portion, described the
Different colors is respectively set in two mark parts and the third mark part.
3. drug use information manages label according to claim 1, which is characterized in that the first identifier portion, described the
Two mark parts and the third mark part are successively arranged from top to bottom.
4. drug use information manages label according to claim 1, which is characterized in that the cut-off rule is point of easily openable
Secant.
5. drug use information manages label according to claim 1, which is characterized in that the first identifier portion, described the
Two mark parts and the third mark part successively from left to right or are from right to left arranged.
6. drug use information manages label according to claim 1, which is characterized in that the fixed part includes threading hole.
7. drug use information manages label according to claim 1, which is characterized in that the fixed part includes for pasting
Adhesive-layer.
8. drug use information manages label according to claim 1, which is characterized in that identified in the first identifier portion
" having been used up ", the second identifier portion identify " use ", and the third mark part successively identifies " being not used ".
9. drug use information manages label according to claim 1, which is characterized in that identified in the first identifier portion
" sky ", the second identifier portion identify " enabling ", and the third mark part successively identifies " full ".
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920160694.3U CN209691227U (en) | 2019-01-29 | 2019-01-29 | A kind of drug use information management label |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920160694.3U CN209691227U (en) | 2019-01-29 | 2019-01-29 | A kind of drug use information management label |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209691227U true CN209691227U (en) | 2019-11-26 |
Family
ID=68600995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201920160694.3U Active CN209691227U (en) | 2019-01-29 | 2019-01-29 | A kind of drug use information management label |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209691227U (en) |
-
2019
- 2019-01-29 CN CN201920160694.3U patent/CN209691227U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102799774A (en) | Method and system for intelligently taking traditional Chinese medicines in prescription | |
| CN209691227U (en) | A kind of drug use information management label | |
| CN106097214A (en) | First-aid dressing approaches to IM based on Quick Response Code | |
| CN109147899A (en) | Method for auditing the preposition careful side of prescribed dose and the frequency | |
| JP2006055392A (en) | Label for medication management | |
| CN209351862U (en) | A kind of blood bag storage bag | |
| Salati et al. | Congenital median upper lip fistula | |
| CN206774121U (en) | One kind transfusion duration display patch | |
| JP3151078U (en) | Label for packaging container and cylindrical packaging container with the label | |
| CN201299781Y (en) | A medicine packaging bag | |
| CN207123988U (en) | A kind of identity device applied on medicine box | |
| CN201859599U (en) | Disposable wrist strap | |
| Ludescher et al. | Interface of drug use | |
| CN214857648U (en) | Medical wrist strap with mark | |
| CN208673611U (en) | The blood label of resistance to water-bath | |
| JP2013169419A (en) | Injection label and method for using the same | |
| CN204618666U (en) | Integral type bedsie card | |
| CN212873859U (en) | Insulin injection pen storage label | |
| CN213736120U (en) | Special medicine box that has instruction function of taking medicine in ward | |
| CN208593645U (en) | One kind is anti-to tear to pieces medicine box | |
| CN207837891U (en) | A kind of band clock alarming function medicament for the eyes water bag | |
| CN208598709U (en) | A kind of dispensary for inpatients single oral dose tears zero medicine placing shelf open | |
| CN209237005U (en) | A kind of retention needle infusion box | |
| CN204521582U (en) | A kind of medicine clad plate | |
| Grissinger | Fatalities after inadvertent injections of topical epinephrine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |